Abstract
Allogeneic gene products of the major histocompatibility complex, the HLA complex in man and the H–2 complex in mice, induce T lymphocytes to exert powerful mixed lymphocyte reactions (MLR) and cell-mediated lympholysis (CML). In mice, the subset of T cells carrying the L3T4 surface antigen but lacking the Lyt-2 antigen responds predominantly to H–2 class II (la) differences whereas the L3T4− Lyt-2+ subset reacts to class I (K/D) differences1,2. For primary responses the stimulus for MLR and CML appears to be controlled by Ia+ cells of the macrophage/dendritic cell lineages, for both L3T4+ and Lyt-2+ cells3–6. The finding that la+ cells are required for responses involving Lyt-2+ cells has been taken to imply that triggering of these cells is controlled by la-restricted L3T4+ cells7,8. Lyt-2+ cells have thus come to be regarded as crippled cells which are heavily dependent on ‘help’ from other T cells9–11. This well-entrenched view is challenged by evidence presented here that purified Lyt-2+ cells can give high primary responses to certain Ia− tumour cells in vitro.
References
- 1.Swain SL. Immun. Rev. 1983;74:129–142. doi: 10.1111/j.1600-065X.1983.tb01087.x. [DOI] [PubMed] [Google Scholar]
- 2.Sprent J, Schaefer M. J. exp. Med. 1985;162:2068–2088. doi: 10.1084/jem.162.6.2068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Shreffler DC, David C. Adv. Immun. 1975;20:125–195. doi: 10.1016/S0065-2776(08)60208-4. [DOI] [PubMed] [Google Scholar]
- 4.Thomas DW, Yamashita U, Shevach EM. Immun. Rev. 1977;35:97–120. doi: 10.1111/j.1600-065X.1977.tb00237.x. [DOI] [PubMed] [Google Scholar]
- 5.Pettinelli CB, Ahmann GB, Shearer GM. J. Immun. 1980;124:1911–1920. [PubMed] [Google Scholar]
- 6.Singer A, Kruisbeek AM, Andrysiak PM. J. Immun. 1984;132:2199–2209. [PubMed] [Google Scholar]
- 7.Weinberger O, Germain RN, Burakoff SL. Nature. 1983;302:429–431. doi: 10.1038/302429a0. [DOI] [PubMed] [Google Scholar]
- 8.Rock KL, Barnes MC, Germain RN, Bernacerraf B. J. Immun. 1983;130:457–462. [PubMed] [Google Scholar]
- 9.Cantor H, Boyse EA. J. exp. Med. 1975;141:1390–1399. doi: 10.1084/jem.141.6.1390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bach FH. Immun. Rev. 1977;35:76–96. doi: 10.1111/j.1600-065X.1977.tb00236.x. [DOI] [PubMed] [Google Scholar]
- 11.Wagner H, Rollinghof M. J. exp. Med. 1978;148:1523–1538. doi: 10.1084/jem.148.6.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.von Boehmer H, Kisielow P, Weiserson W, Haas W. J. Immun. 1984;133:59–64. [PubMed] [Google Scholar]
- 13.Lafferty KJ, Andrus L, Prowse T. Immun. Rev. 1980;51:279–314. doi: 10.1111/j.1600-065X.1980.tb00325.x. [DOI] [PubMed] [Google Scholar]
- 14.Rammensee H-G, Fink PJ, Bevan MJ. J. Immun. 1984;133:2390–2396. [PubMed] [Google Scholar]
- 15.Romani L, Mage MG. Eur. J. Immun. 1985;15:1125–1130. doi: 10.1002/eji.1830151111. [DOI] [PubMed] [Google Scholar]